Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.20B.
ENTERPRISE VALUE (EV)
$3.20B
Veracyte, Inc.
Market Cap
$3.56B
Enterprise Value (EV)
$3.20B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Veracyte, Inc. (VCYT) | $3.56B | $3.20B |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | $3.25B |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | $3.42B |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | $4.00B |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | $3.64B |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | $3.24B |
| Celcuity Inc. (CELC)vs › | $3.47B | $4.05B |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | $3.35B |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | $3.07B |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | $2.32B |
Market Cap
$3.56B
Total Debt
$0.00
Cash
$362.58M
Enterprise Value
$3.20B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
